Thalassemia
Showing NaN - NaN of 9
Beta-Thalassemia, Thalassemia, Genetic Diseases, Inborn Trial in Nashville (CTX001)
Recruiting
- Beta-Thalassemia
- +4 more
- CTX001
-
Nashville, Tennessee
- +5 more
Feb 2, 2023
Beta-Thalassemia, Thalassemia, Genetic Diseases, Inborn Trial in Worldwide (CTX001)
Active, not recruiting
- Beta-Thalassemia
- +4 more
- CTX001
-
Stanford, California
- +11 more
Nov 30, 2022
A Long-term Follow-up Study in Subjects Who Received CTX001
Enrolling by invitation
- Beta-Thalassemia
- +6 more
- CTX001
-
New York, New York
- +12 more
Nov 18, 2022
Multi-Center Study of Iron Overload: Pilot Study
Completed
- Sickle Cell Disease
- +2 more
-
Oakland, California
- +2 more
Sep 22, 2020
Multi-Center Study of Iron Overload: Survey Study (MCSIO)
Completed
- Sickle Cell Disease
- +2 more
-
Oakland, California
- +7 more
Sep 22, 2020
Hepatitis C, Thalassemia Trial in Canada, United Kingdom, United States (Peginterferon Alfa-2a and Ribavirin, Ribavirin)
Completed
- Hepatitis C
- Thalassemia
- Peginterferon Alfa-2a and Ribavirin
- Ribavirin
-
Oakland, California
- +4 more
Mar 3, 2014
People With Thalassemia: The Thalassemia Longitudinal Cohort
Completed
- Thalassemia
-
Los Angeles, California
- +13 more
Nov 9, 2011